FDA Pilots AI-Driven Clinical Trials Using Real-Time EHR Data

The FDA announced piloting an AI-driven approach to clinical trials that enables real-time data extraction directly from electronic health records.

For small to mid-sized biotech firms, the "data feedback loop" has historically been a make-or-break bottleneck. This move could change everything:

1) Faster "Go/No-Go" Decisions: No more waiting months for manual data entry. Real-time visibility means identifying winners (and cutting losses) faster than ever.
2) Capital Efficiency: For startups, time is literally money. Shortening the path to a data readout can be the difference between a successful Series B and running out of runway.
3) Leveling the Playing Field: By automating data capture, smaller teams can run leaner trials and access a broader range of clinical sites, not just the overbooked major academic centers.
4) Accelerated Cures: Most importantly, the goal is to get life-saving therapies to patients months—or years—sooner.

The manual clinical trial data entry is finally facing its AI disruption. For those of us in the ecosystem, the focus now shifts to how quickly we can integrate these tech-enabled workflows to stay competitive.

https://lnkd.in/g4sSdy5K